Powered by
CANTON TWP.–TrialAssure, a software company focused on developing clinical trial transparency tools, announced the launch of TrialResults.com, a new portal for sponsors to publicly share plain-language layperson summaries with clinical …
ANN ARBOR — Esperion Therapeutics Inc. (Nasdaq: ESPR), the Ann Arbor-based pharmaceutical developer, announced positive results from the final Phase 3 test of its lead drug candidate, bempedoic acid. The …
ANN ARBOR — The pharma startup Millendo Therapeutics Inc. announced the start of a Phase 2b clinical trial to assess the efficacy of drug candidate MLE4901, a non-hormonal therapy for …